N
Niagen Bioscience Inc
NAGE · NASDAQ · Healthcare · 241M
Price · close
$3.21
+1.90% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
14.6×
Price / net assetsP/B
3.3×
Enterprise value / EBITDAEV/EBITDA
9.8×
Free cash flow yieldFCF yield
5.2%
Return on equityROE
22.7%
Operating margin
11.0%
Net debt / EBITDAbalance-sheet strength
-3.2×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.